BACKGROUND: Hematoma volume is a major determinant of outcome in patients with intracerebral hemorrhage (ICH). Accurate volume measurements are critical for predicting outcome and are thought to be more difficult in patients with oral anticoagulation-related ICH (OAT-ICH) due to a higher frequency of irregular shape. We examined hematoma shape and methods of volume assessment in patients with OAT-ICH. METHODS: We performed a case-control analysis of a prospectively identified cohort of consecutive patients with ICH. We retrospectively reviewed 50 consecutive patients with OAT-ICH and 50 location-matched non-OAT-ICH controls. Two independent readers analyzed CT scans for hematoma shape and volume using both ABC/2 and ABC/3 methods. Readers were blinded to all clinical variables including warfarin status. Gold-standard ICH volumes were determined using validated computer-assisted planimetry. RESULTS: Within this cohort, median INR in patients with OAT-ICH was 3.2. Initial ICH volume was not significantly different between non-OAT-ICH and OAT-ICH (35 +/- 38 cc vs. 53 +/- 56 cc, P = 0.4). ICH shape did not differ by anticoagulation status (round shape in 10% of OAT-ICH vs. 16% of non-OAT-ICH, P = 0.5). The ABC/3 calculation underestimated median volume by 9 (3-28) cc, while the ABC/2 calculation did so by 4 (0.8-12) cc. CONCLUSIONS: Hematoma shape was not statistically significantly different in patients with OAT-ICH. Among bedside approaches, the standard ABC/2 method offers reasonable approximation of hematoma volume in OAT-ICH and non-OAT-ICH.
BACKGROUND:Hematoma volume is a major determinant of outcome in patients with intracerebral hemorrhage (ICH). Accurate volume measurements are critical for predicting outcome and are thought to be more difficult in patients with oral anticoagulation-related ICH (OAT-ICH) due to a higher frequency of irregular shape. We examined hematoma shape and methods of volume assessment in patients with OAT-ICH. METHODS: We performed a case-control analysis of a prospectively identified cohort of consecutive patients with ICH. We retrospectively reviewed 50 consecutive patients with OAT-ICH and 50 location-matched non-OAT-ICH controls. Two independent readers analyzed CT scans for hematoma shape and volume using both ABC/2 and ABC/3 methods. Readers were blinded to all clinical variables including warfarin status. Gold-standard ICH volumes were determined using validated computer-assisted planimetry. RESULTS: Within this cohort, median INR in patients with OAT-ICH was 3.2. Initial ICH volume was not significantly different between non-OAT-ICH and OAT-ICH (35 +/- 38 cc vs. 53 +/- 56 cc, P = 0.4). ICH shape did not differ by anticoagulation status (round shape in 10% of OAT-ICH vs. 16% of non-OAT-ICH, P = 0.5). The ABC/3 calculation underestimated median volume by 9 (3-28) cc, while the ABC/2 calculation did so by 4 (0.8-12) cc. CONCLUSIONS:Hematoma shape was not statistically significantly different in patients with OAT-ICH. Among bedside approaches, the standard ABC/2 method offers reasonable approximation of hematoma volume in OAT-ICH and non-OAT-ICH.
Authors: H C O'Donnell; J Rosand; K A Knudsen; K L Furie; A Z Segal; R I Chiu; D Ikeda; S M Greenberg Journal: N Engl J Med Date: 2000-01-27 Impact factor: 91.245
Authors: Stephan A Mayer; Nikolai C Brun; Kamilla Begtrup; Joseph Broderick; Stephen Davis; Michael N Diringer; Brett E Skolnick; Thorsten Steiner Journal: N Engl J Med Date: 2005-02-24 Impact factor: 91.245
Authors: J M Gebel; C A Sila; M A Sloan; C B Granger; J P Weisenberger; C L Green; E J Topol; K W Mahaffey Journal: Stroke Date: 1998-09 Impact factor: 7.914
Authors: Christen D Barras; Brian M Tress; Soren Christensen; Lachlan MacGregor; Marnie Collins; Patricia M Desmond; Brett E Skolnick; Stephan A Mayer; Joseph P Broderick; Michael N Diringer; Thorsten Steiner; Stephen M Davis Journal: Stroke Date: 2009-03-12 Impact factor: 7.914
Authors: Stephan A Mayer; Nikolai C Brun; Kamilla Begtrup; Joseph Broderick; Stephen Davis; Michael N Diringer; Brett E Skolnick; Thorsten Steiner Journal: N Engl J Med Date: 2008-05-15 Impact factor: 91.245
Authors: Joshua M Levine; Ryan Snider; David Finkelstein; Mahmut E Gurol; Rishi Chanderraj; Eric E Smith; Steven M Greenberg; Jonathan Rosand Journal: Neurocrit Care Date: 2007 Impact factor: 3.210
Authors: William D Freeman; Kevin M Barrett; Joseph M Bestic; James F Meschia; Daniel F Broderick; Thomas G Brott Journal: Neurocrit Care Date: 2008 Impact factor: 3.210
Authors: Natalia S Rost; Eric E Smith; Yuchiao Chang; Ryan W Snider; Rishi Chanderraj; Kristin Schwab; Emily FitzMaurice; Lauren Wendell; Joshua N Goldstein; Steven M Greenberg; Jonathan Rosand Journal: Stroke Date: 2008-06-12 Impact factor: 7.914
Authors: Jesse J Corry; Ganesh Asaithambi; Arif M Shaik; Jeffrey P Lassig; Emily H Marino; Bridget M Ho; Amy L Castle; Nilanjana Banerji; Megan E Tipps Journal: Clin Drug Investig Date: 2020-05 Impact factor: 2.859
Authors: Charles F Opalak; Matthew Parry; Andrew K Rock; Adam P Sima; Matthew T Carr; Vyshak Chandra; Kathryn G Workman; Aravind Somasundaram; William C Broaddus Journal: J Neurooncol Date: 2019-08-10 Impact factor: 4.130
Authors: Alastair J S Webb; Natalie L Ullman; Tim C Morgan; John Muschelli; Joshua Kornbluth; Issam A Awad; Stephen Mayo; Michael Rosenblum; Wendy Ziai; Mario Zuccarrello; Francois Aldrich; Sayona John; Sagi Harnof; George Lopez; William C Broaddus; Christine Wijman; Paul Vespa; Ross Bullock; Stephen J Haines; Salvador Cruz-Flores; Stan Tuhrim; Michael D Hill; Raj Narayan; Daniel F Hanley Journal: Stroke Date: 2015-08-04 Impact factor: 7.914
Authors: Candice Delcourt; Cheryl Carcel; Danni Zheng; Shoichiro Sato; Hisatomi Arima; Sonu Bhaskar; Pierre Janin; Rustam Al-Shahi Salman; Yongjun Cao; Shihong Zhang; Emma Heeley; Leo Davies; John Chalmers; Craig S Anderson Journal: Cerebrovasc Dis Extra Date: 2019-12-13
Authors: Małgorzata M Miller; Jessica Lowe; Muhib Khan; Muhammad U Azeem; Susanne Muehlschlegel; Adalia H Jun-O'Connell; Richard P Goddeau; Majaz Moonis; Danielle Gritters; Brian Silver; Nils Henninger Journal: Neurocrit Care Date: 2019-08 Impact factor: 3.210